Please login to the form below

Not currently logged in
Email:
Password:

Market access

This Market access section features Market access companies, inc health economics; pricing and reimbursement.

pharmaLevers GmbH

pharmaLevers GmbH is a Swiss based life science consulting firm in the area of Market Access (Pricing & Reimbursement, Health Economy, HTA and Policy).

PharmaPrice International Ltd

PPi specialises in providing guidance and implementation services for healthcare provision. PPi supports the development of market access strategies as well as the ultimate implementation of such strategies. We accomplish this through our intimate understanding of country healthcare systems and our relationships with payers, physicians, pharmacists and other key stakeholders.

Policy Matters LLP

Founded in 2000, Policy Matters is a healthcare-dedicated, independent, market access consultancy that matches healthcare policy to business to help our clients benefit from the opportunities created by the changing NHS landscape. At Policy Matters we help our clients put market access at the heart of their marketing and market development activities and align the company and brand with customers' needs.

Premark Services Ltd

Consultancy service to the Pharmaceutical Industry on the strategy required to build Stakeholder Value into a product

Prescribing support services

PSS is one of the largest nhs medicines management providers in the UK. We work with a range of partners to deliver practice /ccg wide disease management proggrammes

Roboleo & Co

Roboleo & Co is an independent, UK based consultancy focused on creating innovative, evidenced-based, Market Access solutions

RTI International

RTI is an independent, nonprofit institute that provides research, development, and technical services to government and commercial clients worldwide. Our mission is to improve the human condition by turning knowledge into practice.

SG Market Access Ltd

SG Market Access specialises in Payor NHS Reimbursement Research Integrated care consensus cost impact and steering groups

UK Healthgateway

Selling to the UK National Health Service is challenging and time consuming. UK HealthGateway gives you the solutions and services to win sales.

Verto Health Consulting Ltd.

Consulting to the the health technology industry, we help achieve brand ambitions by optimizing how brands are appraised, positioned and commissioned into the health system.

Visions4health Ltd

Visions4health™ are an established healthcare network agency specialising in market access. We have a proven track record of redefining market access for our clients. Visions4health™

Wickenstones

Mapping market access for success

1 2

Featured jobs

Latest content from PMHub

A Lucid Induction
Lucid Group kick off 2016 with six new employees Lucid Group Communications Limited
2016 brings new faces to emotive
emotive appoints Chloë Duval as the new Head of Copy, and Elise Payne joins as a Team Assistant. emotive
What pharma needs to know about genomic data in 2016
Consultant David Cooney from Blue Latitude Health talks us through what this progress in genomics means for pharma in 2016. Blue Latitude Health
Part Two: The First Amendment: Physician education using off-label indications to ensure that patients receive the most effective treatment.
In today’s medical environment there is a two-fold element of risk that affects a medical device company. It is comprised on the one hand by the risk of improper treatment through the agent’s lack of scientific disease state knowledge, and on the other by the medical device company’s fiduciary duty to ensure patient safety, including the facilitation of proper education to the physician. The body of law that regulates the marketing of medical device products in the United States is the Drug and Cosmetic Act, which places a restriction on off-label marketing and advertising. To date, proponents have argued that off-label utilization is a First Amendment right necessary to ensure that patients receive the most effective treatment. Nascent Medical LLC